Breaking News Instant updates and real-time market news.

HSIC

Henry Schein

$63.11

0.73 (1.17%)

07:03
02/20/19
02/20
07:03
02/20/19
07:03

Henry Schein sees FY19 adjusted EPS $3.38-$3.46, consensus $3.75

2019 non-GAAP diluted EPS from continuing operations attributable to Henry Schein, Inc. is expected to be $3.38 to $3.46, reflecting growth of 7% to 9% compared with 2018 non-GAAP diluted EPS from continuing operations of $3.17. The Company's Animal Health business was spun off to shareholders as of February 7, 2019, and that business will be classified as a discontinued operation for all current and prior periods presented.

  • 20

    Feb

HSIC Henry Schein
$63.11

0.73 (1.17%)

01/03/19
EVER
01/03/19
DOWNGRADE
EVER
Underperform
Henry Schein downgraded to Underperform at Evercore ISI
As previously reported, Evercore ISI downgraded Henry Schein to Underperform from In Line. Analyst Ross Muken remains negative on the Dental complex given long-term risks to margins due to pricing, competition, and disintermediation. Muken expects a moderation in the company's share gains in consumables/high-tech equipment, and said the CVET spin is near completion with underling profit likely lower short-term.
01/17/19
UBSW
01/17/19
INITIATION
Target $73
UBSW
Sell
Henry Schein initiated with a Sell at UBS
UBS analyst Kevin Caliendo started Henry Schein with a Sell rating and $73 price target. The analyst's long-term EBIT and earnings estimates are below consensus as he expects ongoing margin pressures to offset Henry Schein's cost saving initiatives and partnership synergies.
02/12/19
RBCM
02/12/19
NO CHANGE
Target $69
RBCM
Sector Perform
Henry Schein price target lowered to $69 from $85 at RBC Capital
RBC Capital analyst Stephen Hagan lowered his price target on Henry Schein to $69 to reflect his updated model after the company's animal health business spin-off. The analyst notes that the spin-off has made shares more attractive, but sees the 18-times forward earnings multiple assumed in his price target as a hurdle to a more positive rating on the shares. Hagan also keeps his Sector Perform rating on Henry Schein.
02/19/19
CHLM
02/19/19
NO CHANGE
Target $72
CHLM
Buy
Henry Schein price target lowered to $72 from $96 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for Henry Schein to $72 from $96 ahead of quarterly results. While the analyst expects the company to report "solid" Q4 results that meet or slightly beat consensus, he believes investors will primarily be focused on FY19 guidance following the spin-off of the animal health business, capital allocation priorities, and management's updated strategy to drive long-term growth and shareholder value. Ellich reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

CHWY

Chewy

$26.44

-1.06 (-3.85%)

06:00
09/23/19
09/23
06:00
09/23/19
06:00
Upgrade
Chewy rating change  »

Nomura Instinet upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$104.03

0.66 (0.64%)

05:56
09/23/19
09/23
05:56
09/23/19
05:56
Hot Stocks
Exact Sciences says Cologuard gains FDA approval for use in ages 45-49 »

Exact Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

APTV

Aptiv

$87.10

-2.41 (-2.69%)

, HYMTF

Hyundai Motor

$0.00

(0.00%)

05:53
09/23/19
09/23
05:53
09/23/19
05:53
Hot Stocks
Aptiv, Hyundai Motor to form autonomous driving JV »

Aptiv (APTV) and Hyundai…

APTV

Aptiv

$87.10

-2.41 (-2.69%)

HYMTF

Hyundai Motor

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$5.29

-0.23 (-4.17%)

05:47
09/23/19
09/23
05:47
09/23/19
05:47
Hot Stocks
Arcadia Biosciences granted U.S. patent for reduced gluten GoodWheat »

Arcadia Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$4.76

-0.1 (-2.06%)

05:38
09/23/19
09/23
05:38
09/23/19
05:38
Hot Stocks
Clovis acquires rights to FAP »

Clovis Oncology has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TRV

Travelers

$146.32

-0.69 (-0.47%)

05:37
09/23/19
09/23
05:37
09/23/19
05:37
Hot Stocks
Travelers receives approval to transfer European business to Dublin »

Travelers announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

DEA

Easterly Government Properties

$20.96

0.02 (0.10%)

05:37
09/23/19
09/23
05:37
09/23/19
05:37
Initiation
Easterly Government Properties initiated  »

Easterly Government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TEL

TE Connectivity

$93.21

-1.21 (-1.28%)

05:34
09/23/19
09/23
05:34
09/23/19
05:34
Downgrade
TE Connectivity rating change  »

TE Connectivity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWDBY

Swedbank

$0.00

(0.00%)

05:33
09/23/19
09/23
05:33
09/23/19
05:33
Upgrade
Swedbank rating change  »

Swedbank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLOY

EssilorLuxottica

$0.00

(0.00%)

05:32
09/23/19
09/23
05:32
09/23/19
05:32
Upgrade
EssilorLuxottica rating change  »

EssilorLuxottica upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHWY

Chewy

$26.44

-1.06 (-3.85%)

05:30
09/23/19
09/23
05:30
09/23/19
05:30
Upgrade
Chewy rating change  »

Chewy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEXAY

Atos

$0.00

(0.00%)

05:29
09/23/19
09/23
05:29
09/23/19
05:29
Upgrade
Atos rating change  »

Atos upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$238.80

3.2 (1.36%)

05:28
09/23/19
09/23
05:28
09/23/19
05:28
Hot Stocks
Biogen says Plegridy, Avonex receive 'positive opinion' from CHMP »

Biogen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ACN

Accenture

$192.99

-1.78 (-0.91%)

05:28
09/23/19
09/23
05:28
09/23/19
05:28
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

TELDF

Telefonica Deutschland

$0.00

(0.00%)

05:27
09/23/19
09/23
05:27
09/23/19
05:27
Upgrade
Telefonica Deutschland rating change  »

Telefonica Deutschland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGY

VAALCO Energy

$2.08

0.06 (2.97%)

05:26
09/23/19
09/23
05:26
09/23/19
05:26
Initiation
VAALCO Energy initiated  »

VAALCO Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$11.64

-0.565 (-4.63%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Hot Stocks
PG&E expects to turn off power late Monday in nine CA counties due to fire risk »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Oct

  • 10

    Nov

  • 10

    Nov

  • 07

    Jan

AIBRF

AIB Group

$0.00

(0.00%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAOFY

Tatneft

$0.00

(0.00%)

05:22
09/23/19
09/23
05:22
09/23/19
05:22
Downgrade
Tatneft rating change  »

Tatneft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:21
09/23/19
09/23
05:21
09/23/19
05:21
Upgrade
easyJet rating change  »

easyJet upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLOWY

Vallourec

$0.00

(0.00%)

05:20
09/23/19
09/23
05:20
09/23/19
05:20
Downgrade
Vallourec rating change  »

Vallourec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELNY

Telenor

$0.00

(0.00%)

05:15
09/23/19
09/23
05:15
09/23/19
05:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANNSF

Aena

$0.00

(0.00%)

05:14
09/23/19
09/23
05:14
09/23/19
05:14
Downgrade
Aena rating change  »

Aena downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

05:13
09/23/19
09/23
05:13
09/23/19
05:13
Recommendations
Apple analyst commentary  »

Piper survey shows higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$154.45

-0.49 (-0.32%)

, ABT

Abbott

$83.56

0.35 (0.42%)

05:04
09/23/19
09/23
05:04
09/23/19
05:04
Recommendations
DexCom, Abbott analyst commentary  »

DexCom remains a…

DXCM

DexCom

$154.45

-0.49 (-0.32%)

ABT

Abbott

$83.56

0.35 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.